SOLS Solstice Advanced Materials Inc.
Chemicals & Allied Products · Nasdaq · SEC CIK 2064953 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY-1.2%
TTM EPS YoY-1.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin30.9%
Operating margin—
Net margin7.8%
FCF margin10.7%
EBITDA margin—
Returns
ROE13.6%
ROA5.7%
ROIC (approx.)—
Asset turnover0.74x
Leverage & solvency
Liabilities / assets74.1%
Debt / equity1.26x
Current ratio1.38x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.64x
Accruals ratio-9.4%
Payout ratio472.6%
Capex / revenue9.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.05B | $1.15B | $991.00M | $987.00M | $969.00M | $1.03B | $897.00M | $913.00M |
| Cost of revenue | $701.00M | $778.00M | $675.00M | $729.00M | $659.00M | $671.00M | $577.00M | $608.00M |
| Gross profit | $345.00M | $370.00M | $316.00M | $258.00M | $310.00M | $362.00M | $320.00M | $305.00M |
| R&D expense | $30.00M | $25.00M | $28.00M | $27.00M | $26.00M | $23.00M | $22.00M | $21.00M |
| SG&A expense | $120.00M | $123.00M | $108.00M | $112.00M | $113.00M | $105.00M | $93.00M | $89.00M |
| Interest expense | $60.00M | $23.00M | $29.00M | $23.00M | $2.00M | $2.00M | $1.00M | $2.00M |
| Pretax income | $112.00M | $176.00M | $136.00M | $86.00M | $173.00M | $199.00M | $188.00M | $176.00M |
| Income tax | $24.00M | $42.00M | $31.00M | $32.00M | $182.00M | $101.00M | $47.00M | $42.00M |
| Net income | $80.00M | $119.00M | $85.00M | $41.00M | -$35.00M | $97.00M | $134.00M | $133.00M |
| EPS (basic) | 0.50 | 0.75 | 0.53 | — | -0.22 | 0.61 | 0.85 | — |
| EPS (diluted) | 0.50 | 0.75 | 0.53 | — | -0.22 | 0.61 | 0.85 | — |
| Dividends declared per share | 0.07 | 0.07 | 0.07 | — | — | — | — | — |
| Weighted avg. shares (diluted) | 159.00M | 159.40M | 159.30M | — | 158.70M | 158.70M | 158.70M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $714.00M | $750.00M | $642.00M | $534.00M | $417.00M | $873.00M | $668.00M | $661.00M |
| Receivables | $667.00M | $671.00M | $632.00M | $645.00M | $635.00M | — | — | $569.00M |
| Inventory | $664.00M | $666.00M | $704.00M | $715.00M | $732.00M | — | — | $558.00M |
| Current assets | $2.68B | $2.57B | $2.44B | $2.39B | $1.88B | — | — | $1.86B |
| PP&E, net | $2.18B | $2.13B | $2.08B | $2.06B | $1.95B | — | — | $1.75B |
| Goodwill | $818.00M | $817.00M | $819.00M | $820.00M | $820.00M | — | — | $806.00M |
| Intangibles | $47.00M | $47.00M | $48.00M | $49.00M | $39.00M | — | — | $35.00M |
| Total assets | $6.07B | $5.92B | $5.75B | $5.67B | $5.25B | — | — | $5.00B |
| Current liabilities | $1.94B | $1.76B | $1.71B | $1.71B | $1.23B | — | — | $1.08B |
| Short-term debt | $5.00M | $6.00M | $6.00M | $4.00M | — | — | — | $0 |
| Long-term debt | $1.96B | $1.97B | $1.97B | $1.97B | — | — | — | $0 |
| Total debt | $1.97B | $1.97B | $1.97B | $1.97B | — | — | — | $0 |
| Total liabilities | $4.50B | $4.33B | $4.28B | $4.30B | $2.07B | — | — | $1.82B |
| Shareholders' equity | $1.56B | $1.59B | $1.49B | $1.41B | $3.23B | $3.47B | $3.23B | $3.26B |
| Net debt | $1.25B | $1.22B | $1.33B | $1.44B | — | — | — | -$661.00M |
| Shares outstanding | 157.21M | 158.80M | 158.80M | 158.75M | — | — | — | 0 |
| Cash flow statement | ||||||||
| Operating cash flow | $232.00M | $262.00M | $199.00M | $166.00M | -$21.00M | $150.00M | $160.00M | $275.00M |
| Capital expenditure | $112.00M | $138.00M | $75.00M | $88.00M | $110.00M | $76.00M | $62.00M | $95.00M |
| Free cash flow | $120.00M | $124.00M | $124.00M | $78.00M | -$131.00M | $74.00M | $98.00M | $180.00M |
| Investing cash flow | -$113.00M | -$138.00M | -$77.00M | -$102.00M | -$110.00M | -$79.00M | -$39.00M | -$94.00M |
| Financing cash flow | -$152.00M | -$16.00M | -$15.00M | $93.00M | -$316.00M | $106.00M | -$118.00M | -$128.00M |
| Depreciation & amortization | $54.00M | $54.00M | $53.00M | -$127.00M | $46.00M | $55.00M | $50.00M | -$87.00M |
| Stock-based compensation | $6.00M | $6.00M | $5.00M | $8.00M | $8.00M | $6.00M | $6.00M | $4.00M |
| Dividends paid | $12.00M | $12.00M | $12.00M | $1.50B | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 9 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.